Global IV Flush Syringe Market Growth 2023-2029

Global IV Flush Syringe Market Growth 2023-2029

This report studies the IV Flush Syringe market. Health care professionals use IV flush syringes to clear out patients’ catheters and intravenous lines to ensure the tubes are sterile. Nurse Assist, a Texas-based medical device manufacturer, recalled all of its Normal Saline IV Flush Syringes in 2016 after the devices spread a bacterial infection. Patients became sick and some died. How the syringes became contaminated with the bacteria Burkholderia cepacia remains unknown.
LPI (LP Information)' newest research report, the “IV Flush Syringe Industry Forecast” looks at past sales and reviews total world IV Flush Syringe sales in 2022, providing a comprehensive analysis by region and market sector of projected IV Flush Syringe sales for 2023 through 2029. With IV Flush Syringe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IV Flush Syringe industry.
This Insight Report provides a comprehensive analysis of the global IV Flush Syringe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IV Flush Syringe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global IV Flush Syringe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IV Flush Syringe and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IV Flush Syringe.
The global IV Flush Syringe market size is projected to grow from US$ 344.3 million in 2022 to US$ 532.7 million in 2029; it is expected to grow at a CAGR of 532.7 from 2023 to 2029.
Global IV Flush Syringe key players include BD, Medtronic, Medline, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 55%, followed by Europe and China, both have a share about 33 percent.
In terms of product, Saline IV Flush Syringe is the largest segment, with a share over 70%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of IV Flush Syringe market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Saline IV Flush Syringe
Heparin IV Flush Syringe
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Medtronic
Medline
Medefil
B. Braun
Cardinal Health
Aquabiliti
Key Questions Addressed in this Report
What is the 10-year outlook for the global IV Flush Syringe market?
What factors are driving IV Flush Syringe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IV Flush Syringe market opportunities vary by end market size?
How does IV Flush Syringe break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.